PubMed:12373350 / 371-526
Annnotations
LitCoin-PubTator-for-Tuning
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 26 | 0-15 | DiseaseOrPhenotypicFeature | denotes | Cardiac failure | MESH:D006333 |
| 27 | 133-146 | ChemicalEntity | denotes | anthracycline | MESH:D018943 |
LitCoin-Disease-Tuning-1
| Id | Subject | Object | Predicate | Lexical cue | ID: |
|---|---|---|---|---|---|
| T10 | 0-15 | DiseaseOrPhenotypicFeature | denotes | Cardiac failure | D006333 |
LitEisuke
| Id | Subject | Object | Predicate | Lexical cue | #label |
|---|---|---|---|---|---|
| T8 | 0-15 | DiseaseOrPhenotypicFeature | denotes | Cardiac failure | D006333 |
sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| TextSentencer_T4 | 0-155 | Sentence | denotes | Cardiac failure occurred progressively after 31-month, 32-month, and 14-month intervals, respectively, following completion of first anthracycline therapy. |
| T4 | 0-155 | Sentence | denotes | Cardiac failure occurred progressively after 31-month, 32-month, and 14-month intervals, respectively, following completion of first anthracycline therapy. |
PubmedHPO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T5 | 0-15 | HP_0001635 | denotes | Cardiac failure |